ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | -66.7% | 1,023 | -55.4% | 0.00% | – |
| Q2 2015 | $3,000 | – | 2,296 | +76433.3% | 0.00% | – |
| Q1 2015 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2014 | $190,000 | – | 182,725 | +1074752.9% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 17 | -99.8% | 0.00% | – |
| Q4 2013 | $10,000 | -76.2% | 8,545 | -65.9% | 0.00% | – |
| Q3 2013 | $42,000 | -79.1% | 25,058 | -75.1% | 0.00% | – |
| Q2 2013 | $201,000 | – | 100,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |